{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:13:39Z","timestamp":1788779619244,"version":"build-2803163510"},"reference-count":33,"publisher":"Baishideng Publishing Group Inc.","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.4779","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T02:18:15Z","timestamp":1219285095000},"page":"4779","source":"Crossref","is-referenced-by-count":14,"title":["Thalidomide effect in endothelial cell of acute radiation proctitis"],"prefix":"10.3748","volume":"14","author":[{"given":"Ki-Tae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiun-Suk","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whang","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Young","family":"Rho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Hauer-Jensen M, Fink LM, Wang J. Radiation injury and the protein C pathway. Crit Care Med 2004;32:S325-S330.","DOI":"10.1097\/01.CCM.0000126358.15697.75"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Boerma M, Kruse JJ, van Loenen M, Klein HR, Bart CI, Zurcher C, Wondergem J. Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation. Strahlenther Onkol 2004;180:109-116.","DOI":"10.1007\/s00066-004-1138-0"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wang J, Boerma M, Fu Q, Hauer-Jensen M. Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 2007;13:3047-3055.","DOI":"10.3748\/wjg.v13.i22.3047"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Molla M, Panes J. Radiation-induced intestinal inflammation. World J Gastroenterol 2007;13:3043-3046.","DOI":"10.3748\/wjg.v13.i22.3043"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Van de Wouwer M, Collen D, Conway EM. Thrombo-modulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004;24:1374-1383.","DOI":"10.1161\/01.ATV.0000134298.25489.92"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Richter KK, Fink LM, Hughes BM, Sung CC, Hauer-Jensen M. Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother Oncol 1997;44:65-71.","DOI":"10.1016\/S0167-8140(97)00063-7"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, Gerlitz B, Repici A, Arena V, Malesci A, Panes J. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 2007;117:1951-1960.","DOI":"10.1172\/JCI31027"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004;126:1593-1610.","DOI":"10.1053\/j.gastro.2004.02.070"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Paravar T, Lee DJ. Thalidomide: mechanisms of action. Int Rev Immunol 2008;27:111-135.","DOI":"10.1080\/08830180801911339"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Carvalho AT, Souza H, Carneiro AJ, Castelo-Branco M, Madi K, Schanaider A, Silv F, Pereira Junior FA, Pereira MG, Tortori C. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. World J Gastroenterol 2007;13:2166-2173.","DOI":"10.3748\/wjg.v13.i15.2166"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Plamondon S, Ng SC, Kamm MA. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies. Aliment Pharmacol Ther 2007;25:557-567.","DOI":"10.1111\/j.1365-2036.2006.03239.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Komorowski J, Jerczy\u0144ska H, Siejka A, Bara\u0144ska P, \u0141awnicka H, Paw\u0142owska Z, Stepie\u0144 H. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells. Life Sci 2006;78:2558-2563.","DOI":"10.1016\/j.lfs.2005.10.016"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-523.","DOI":"10.1097\/00054725-200606000-00012"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chidlow JH Jr, Langston W, Greer JJ, Ostanin D, Abdelbaqi M, Houghton J, Senthilkumar A, Shukla D, Mazar AP, Grisham MB. Differential angiogenic regulation of experimental colitis. Am J Pathol 2006;169:2014-2030.","DOI":"10.2353\/ajpath.2006.051021"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Taha Y, Raab Y, Larsson A, Carlson M, Loof L, Gerdin B, Thorn M. Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci 2004;49:109-115.","DOI":"10.1023\/B:DDAS.0000011611.92440.f2"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Northway MG, Scobey MW, Geisinger KR. Radiation proctitis in the rat. Sequential changes and effects of anti-inflammatory agents. Cancer 1988;62:1962-1969.","DOI":"10.1002\/1097-0142(19881101)62:9<1962::AID-CNCR2820620916>3.0.CO;2-T"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Smith JM, Meinkoth JH, Hochstatter T, Meyers KM. Differential distribution of von Willebrand factor in canine vascular endothelium. Am J Vet Res 1996;57:750-755.","DOI":"10.2460\/ajvr.1996.57.05.750"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Weidner N, Gasparini G. Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Cancer Res Treat 1994;29:97-107.","DOI":"10.1007\/BF00666185"},{"key":"ref19","unstructured":"R&uuml;be CE, Rodemann HP, R&uuml;be CE. [The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance]. Strahlenther Onkol 2004;180:541-549."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Linard C, Marquette C, Mathieu J, Pennequin A, Clarennon D, Mathe D. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor. Int J Radiat Oncol Biol Phys 2004;58:427-434.","DOI":"10.1016\/j.ijrobp.2003.09.039"},{"key":"ref21","unstructured":"Rodel F, Hantschel M, Hildebrandt G, Schultze-Mosgau S, Rodel C, Herrmann M, Sauer R, Voll RE. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int J Radiat Biol 2004;80:115-123."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Majumdar S, Lamothe B, Aggarwal BB. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J Immunol 2002;168:2644-2651.","DOI":"10.4049\/jimmunol.168.6.2644"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bowcock SJ, Rassam SM, Ward SM, Turner JT, Laffan M. Thromboembolism in patients on thalidomide for myeloma. Hematology 2002;7:51-53.","DOI":"10.1080\/10245330290020126"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Corso A, Lorenzi A, Terulla V, Airo F, Varettoni M, Mangiacavalli S, Zappasodi P, Rusconi C, Lazzarino M. Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone. Ann Hematol 2004;83:588-591.","DOI":"10.1007\/s00277-004-0891-6"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Petropoulou AD, Gerotziafas GT, Samama MM, Hatmi M, Rendu F, Elalamy I. In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide. Thromb Res 2008;121:493-497.","DOI":"10.1016\/j.thromres.2007.05.016"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Eleutherakis-Papaiakovou V. Adverse effects of thalidomide administration in patients with neoplastic diseases. Am J Med 2004;117:508-515.","DOI":"10.1016\/j.amjmed.2004.03.040"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-265.","DOI":"10.1016\/S0008-6363(97)00039-4"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Pearson JD. Markers of endothelial perturbation and damage. Br J Rheumatol 1993;32:651-652.","DOI":"10.1093\/rheumatology\/32.8.651"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001;50:851-855.","DOI":"10.1016\/S0360-3016(01)01593-0"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans 2002;30:173-177.","DOI":"10.1042\/bst0300173"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999;274:23969-23976.","DOI":"10.1074\/jbc.274.34.23969"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Tsopanoglou NE, Pipili-Synetos E, Maragoudakis ME. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 1993;264:C1302-C1307.","DOI":"10.1152\/ajpcell.1993.264.5.C1302"},{"key":"ref33","unstructured":"Koukourakis MI, Flordellis CS, Giatromanolaki A, Koukouraki S, Kapsoritakis A, Potamianos S, Retalis G, Sivridis E, Salsaa B, Harris AL. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis. Clin Cancer Res 1999;5:3970-3976."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i30\/4779.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T11:55:20Z","timestamp":1709207720000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i30\/4779.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":33,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.4779","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}